Sponsor pipeline

Suzhou Alphamab Co., Ltd. clinical trial pipeline

Get alerts when Suzhou Alphamab Co., Ltd.'s trials change

8 active trials 4 recruiting 3 Phase 3 4 disease areas

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

Active trials by phase

Phase 1
2
Phase 1/2
1
Phase 2
2
Phase 3
3

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT07545395 Safety of KN057 Prophylaxis in Patients With Haemophilia A or B Hemophilia A or B Recruiting 2026-04-22
NCT06312475 Efficacy and Safety of KN057 Prophylaxis in Patients With Haemophilia A or B With… Hemophilia A With Inhibitor Active, Not Recruiting 2025-09-17
NCT06569108 Efficacy and Safety of KN057 Prophylaxis in Patients With Haemophilia A or B Without… Hemophilia A Without Inhibitor Active, Not Recruiting 2025-09-17
Phase 2
NCT06180889 Factor XI inhibiTion for the Prevention of Venous Thromboembolism in Patients Undergoing… Knee Arthroplasty, Total Active, Not Recruiting 2025-09-17
NCT06747416 KN057 Multiple Dose Study in Patients with Hemophilia a or Hemophilia B with or Without… Hemophilia a and B Not Yet Recruiting 2024-12-24
Phase 1/2
NCT07201467 To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of KN060 in… End-Stage Renal Disease Requiring Haemodialysis Recruiting 2025-10-01
Phase 1
NCT07191899 To Evaluate the Efficacy and Safety of KN060 in Essential Hypertension Hypertension Recruiting 2025-09-25
NCT06547775 A Study to Evaluate Features of KN069 in Participants With Obesity or Overweight Overweight or Obesity Recruiting 2025-09-17

Disease areas by active trials

Get alerts when Suzhou Alphamab Co., Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free